China approves use of Pfizer's COVID drug Paxlovid - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

ประเทศไทย ข่าว ข่าว

ประเทศไทย ข่าวล่าสุด,ประเทศไทย หัวข้อข่าว

China’s medical products regulator gives conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the country. COVID19 OralPill Pfizer

Coronavirus disease treatment pill Paxlovid is seen in a box, at Misericordia hospital in Grosseto, Italy, February 8, 2022.

The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.“This is an important milestone in our fight against COVID-19,” a Pfizer representative said in a statement, without providing information about procurement.

Pfizer in December said final trial results showed its treatment reduced the chance of hospitalisation or death by 89% in COVID-19 patients at risk of severe illness given the treatment within three days of the onset of symptoms, and by 88% when given within five days of onset. China has kept a daily number of new COVID-19 patients with confirmed symptoms to below 250 and sometimes fewer than 10, in the past year.

 

ขอบคุณสำหรับความคิดเห็นของคุณ ความคิดเห็นของคุณจะถูกเผยแพร่หลังจากได้รับการตรวจสอบแล้ว

still in China 🇨🇳🇨🇳.. ... I'm still not interested about vaccines PASS PORT 🥂🥂🥂🇿🇦🇿🇦🇿🇦🇿🇦

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

 /  🏆 37. in TH

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว